Inhibition of sialidase activity as a therapeutic approach

References

• SamrajANLäubliHVarkiNVarkiAInvolvement of a non-human sialic Acid in human cancerFront Oncol201443324600589
   PubMedGoogle Scholar
• MiyagiTYamaguchiKMammalian sialidases: physiological and pathological roles in cellular functionsGlycobiology201222788089622377912
   PubMed Web of Science ®Google Scholar
• ZhangZWuhrerMHolstSSerum sialylation changes in cancerGlycoconj J201835213916029680984
   PubMed Web of Science ®Google Scholar
• ClineTDBeckDBianchiniEInfluenza virus replication in macrophages: balancing protection and pathogenesisJ Gen Virol201798102401241228884667
   PubMed Web of Science ®Google Scholar
• von ItzsteinMWuWYKokGBRational design of potent sialidase-based inhibitors of influenza virus replicationNature199336364284184238502295
   PubMed Web of Science ®Google Scholar
• MallipeddiPLKumarGWhiteSWWebbTRRecent advances in computer-aided drug design as applied to anti-influenza drug discoveryCurr Top Med Chem201414161875188925262796
   PubMed Web of Science ®Google Scholar
• GrienkeUSchmidtkeMvon GrafensteinSKirchmairJLiedlKRRollingerJMInfluenza neuraminidase: a druggable target for natural productsNat Prod Rep2012291113622025274
   PubMed Web of Science ®Google Scholar
• HsuKCHungHCHuangFuWCIdentification of neuraminidase inhibitors against dual H274Y/I222R mutant strainsSci Rep2017711233628951584
   PubMed Web of Science ®Google Scholar
• VavrickaCJMutoCHasunumaTSynthesis of Sulfo-Sialic Acid Analogues: Potent Neuraminidase Inhibitors in Regards to Anomeric FunctionalitySci Rep201771823928811524
   PubMed Web of Science ®Google Scholar
• ColomboCPodlipnikČLo PrestiLNiikuraMBennetAJBernardiADesign and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidasePLoS One2018132e019362329489903
   PubMed Web of Science ®Google Scholar
• ChamniSDe-EknamkulWRecent progress and challenges in the discovery of new neuraminidase inhibitorsExpert Opin Ther Pat201323440942323369206
   PubMed Web of Science ®Google Scholar
• BelardoGCenciarelliOLa FraziaSRossignolJFSantoroMGSynergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitroAntimicrob Agents Chemother20155921061106925451059
   PubMed Web of Science ®Google Scholar
• ZhangLAiHXLiSMVirtual screening approach to identifying influenza virus neuraminidase inhibitors using molecular docking combined with machine-learning-based scoring functionOncotarget2017847831428315429137330
   PubMedGoogle Scholar
• IkramNKDurrantJDMuchtaridiMA virtual screening approach for identifying plants with anti H5N1 neuraminidase activityJ Chem Inf Model201555230831625555059
   PubMed Web of Science ®Google Scholar
• ZhuQBangTHOhnukiKSawaiTSawaiKShimizuKInhibition of neuraminidase by Ganoderma triterpenoids and implications for neuraminidase inhibitor designSci Rep201551319426307417
   PubMed Web of Science ®Google Scholar
• ZhaoYMWangLHLuoSFMagnetic beads-based neuraminidase enzyme microreactor as a drug discovery tool for screening inhibitors from compound libraries and fishing ligands from natural productsJ Chromatogr A2018156812313030005943
   PubMed Web of Science ®Google Scholar
• LiuJZuMChenKScreening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicinesBMC Complement Altern Med201818110229558938
   PubMed Web of Science ®Google Scholar
• LiuFCaoWDengCWuZZengGZhouYPolyphenolic glycosides isolated from Pogostemon cablin (Blanco) Benth as novel influenza neuraminidase inhibitorsChem Cent J2016105127516808
   PubMedGoogle Scholar
• EnkhtaivanGMuthuramanPKimDHMistryBDiscovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidaseBioorg Med Chem201725205185519328958846
   PubMed Web of Science ®Google Scholar
• IdeKKawasakiYKawakamiKYamadaHAnti-influenza virus effects of catechins: A molecular and clinical reviewCurr Med Chem201623424773478327881069
   PubMed Web of Science ®Google Scholar
• GilbertsonBNgWCCrawfordSMcKimm-BreschkinJLBrownLEMouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase ActivityJ Virol20179114e001451728446666
   PubMed Web of Science ®Google Scholar
• ChengCKTsaiCHShieJJFangJMFrom neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Future Med Chem20146775777424941871
   PubMed Web of Science ®Google Scholar
• World Health OrganizationInfluenza at the human-animal interfaceSummary and assessment, 26 January to 2 March 2018201815 Available from: http://www.who.int/entity/influenza/human_animal_interface/Influenza_Summary_IRA_HA_interface_09_27_2017. pdf?ua=1Accessed April 1, 2018
   Google Scholar
• NikolaidisNMNoelJGPitstickLBMitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infectionProc Natl Acad Sci U S A201711432E6613E662228739896
   PubMed Web of Science ®Google Scholar
• ZaninMDuanSWongSSAn Amino Acid in the Stalk Domain of N1 Neuraminidase Is Critical for Enzymatic ActivityJ Virol2017912e008681627847354
   PubMed Web of Science ®Google Scholar
• BurnhamAJBaranovichTGovorkovaEANeuraminidase inhibitors for influenza B virus infection: efficacy and resistanceAntiviral Res2013100252053424013000
   PubMed Web of Science ®Google Scholar
• McKimm-BreschkinJLInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceInfluenza Other Respir Viruses20137Suppl 1253623279894
   PubMed Web of Science ®Google Scholar
• KerryPSMohanSRussellRJBanceNNiikuraMPintoBMStructural basis for a class of nanomolar influenza A neuraminidase inhibitorsSci Rep20133287124129600
   PubMed Web of Science ®Google Scholar
• GubarevaLVBesselaarTGDanielsRSGlobal update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016Antiviral Res2017146122028802866
   PubMed Web of Science ®Google Scholar
• TyrrellBESayceACWarfieldKLMillerJLZitzmannNIminosugars: Promising therapeutics for influenza infectionCrit Rev Microbiol201743552154527931136
   PubMed Web of Science ®Google Scholar
• McCombsJEDiazJPLuebkeKJKohlerJJGlycan specificity of neuraminidases determined in microarray formatCarbohydr Res2016428314027131125
   PubMed Web of Science ®Google Scholar
• WaltherERichterMXuZAntipneumococcal activity of neuraminidase inhibiting artocarpinInt J Med Microbiol2015305328929725592264
   PubMed Web of Science ®Google Scholar
• HyunSWLiuALiuZThe NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivoGlycobiology201626883484927226251
   PubMed Web of Science ®Google Scholar
• HaxhoFNeufeldRJSzewczukMRNeuraminidase-1: a novel therapeutic target in multistage tumorigenesisOncotarget2016726408604088127029067
   PubMedGoogle Scholar
• KarhadkarTRPillingDCoxNGomerRHSialidase inhibitors attenuate pulmonary fibrosis in a mouse modelSci Rep2017711506929118338
   PubMed Web of Science ®Google Scholar
• GranerSSvenssonTBeauABNeuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register studyBMJ2017356j62928246106
   PubMed Web of Science ®Google Scholar
• BradburyNNguyen-Van-TamJLimWSClinicians’ attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenzaBMC Health Serv Res201818131129716584
   PubMed Web of Science ®Google Scholar
• de OliveiraJTSantosALGomesCAnti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressivenessPLoS One2015104e012159025850034
   PubMed Web of Science ®Google Scholar
• EbellMHWHO downgrades status of oseltamivirBMJ2017358j326628701339
   PubMed Web of Science ®Google Scholar
• HsiehNHLinYJYangYFLiaoCMAssessing the oseltamivir-induced resistance risk and implications for influenza infection control strategiesInfect Drug Resist20171021522628790857
   PubMed Web of Science ®Google Scholar
• LackenbyABesselaarTGDanielsRSGlobal update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017Antiviral Res2018157384629981793
   PubMed Web of Science ®Google Scholar
• SinghASolimanMEUnderstanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analysesDrug Des Devel Ther2015941374154
   PubMed Web of Science ®Google Scholar
• ThorlundKAwadTBoivinGThabaneLSystematic review of influenza resistance to the neuraminidase inhibitorsBMC Infect Dis20111113421592407
   PubMed Web of Science ®Google Scholar
• DirrLEl-DeebIMChavasLMGGuillonPItzsteinMVThe impact of the butterfly effect on human parainfluenza virus haemagglutinin-neuraminidase inhibitor designSci Rep201771450728674426
   PubMed Web of Science ®Google Scholar
• LiaoLEKowalSCardenasDABeaucheminCAAExploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitorsPLoS One2017128e018362128837615
   PubMed Web of Science ®Google Scholar
• ItohYShichinoheSNakayamaMEmergence of H7N9 influenza A virus resistant to neuraminidase inhibitors in nonhuman primatesAntimicrob Agents Chemother20155984962497326055368
   PubMed Web of Science ®Google Scholar